On this episode of the JVRD Author’s Forum podcast, retina specialist Manjot K. Gill, MD, MS, discusses her article, “Patients at Elevated Risk for Heart Failure Exhibit Reduced Retinal Perfusion,” published in the Journal of VitreoRetinal Diseases.

Host Dr. Timothy Murray speaks with Dr. Gill about the emerging field of oculomics and the potential for retinal imaging to detect systemic disease before clinical symptoms develop. Using OCT angiography (OCTA), the study evaluated patients at elevated 10-year risk for heart failure and found reduced retinal perfusion compared with age-matched controls.

The discussion highlights how retinal imaging may offer a noninvasive biomarker for identifying patients with subclinical cardiovascular disease, supporting earlier intervention and more personalized risk assessment. Dr. Gill also explores how advances in OCTA and artificial intelligence are expanding the role of the retina in understanding systemic health and disease.

For more information, visit www.ASRS.org/JVRDForum.

Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. As the official peer-reviewed scientific journal of the American Society of Retina Specialists (ASRS), JVRD delivers rigorous, clinically meaningful research that informs and advances retina care worldwide. Join Editor-in-Chief Dr. Timothy Murray as he engages leading investigators in thoughtful discussions about the latest studies published in JVRD — highlighting practical insights, clinical pearls, and the real-world impact of emerging innovations in our field.

On this episode of the JVRD Author’s Forum podcast, retina specialist Sally Ong discusses her article, “The Impact of Socioeconomic Deprivation on Anti–Vascular Endothelial Growth Factor Therapy and Ocular Response in Patients With Diabetic Macular Edema,” published in the Journal of VitreoRetinal Diseases.

Host Dr. Timothy Murray speaks with Dr. Ong about how socioeconomic disadvantage may affect anti-VEGF treatment and outcomes in patients with diabetic macular edema. Using the Area Deprivation Index (ADI), the study found no significant differences in injection frequency or retinal anatomy between groups, though patients with less socioeconomic disadvantage had better visual acuity at two years and were more likely to undergo cataract surgery. The discussion also highlights the importance of patient education, coordinated diabetes care, and proactive follow-up to help patients preserve vision.

For more information, visit www.ASRS.org/JVRDForum.

Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. As the official peer-reviewed scientific journal of the American Society of Retina Specialists (ASRS), JVRD delivers rigorous, clinically meaningful research that informs and advances retina care worldwide. Join Editor-in-Chief Dr. Timothy Murray as he engages leading investigators in thoughtful discussions about the latest studies published in JVRD — highlighting practical insights, clinical pearls, and the real-world impact of emerging innovations in our field.

On this episode of the JVRD Author’s Forum podcast, retina specialist Alan J. Ruby discusses his study, “Outer Retinal Optical Coherence Tomography Changes Associated with Intraocular Silicone Oil Administration,” published in Journal of VitreoRetinal Diseases (JVRD).

Host Timothy G. Murray speaks with Dr. Ruby about the use of OCT imaging in patients undergoing silicone oil removal following retinal detachment repair. The discussion explores how subtle outer retinal and ellipsoid zone changes identified on preoperative OCT imaging frequently resolved after silicone oil removal, even when visual outcomes did not always correlate with the imaging findings.

Dr. Ruby explains how the study evaluated both macula-on and macula-off retinal detachments and highlights the importance of obtaining OCT imaging while silicone oil remains in the eye. The conversation also examines longstanding questions surrounding unexplained vision changes after silicone oil use, the potential role of imaging in guiding the timing of oil removal, and why routine postoperative imaging may improve surgical planning and patient management.

For more information, visit www.ASRS.org/JVRDForum.

Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. As the official peer-reviewed scientific journal of the American Society of Retina Specialists (ASRS), JVRD delivers rigorous, clinically meaningful research that informs and advances retina care worldwide. Join Editor-in-Chief Dr. Timothy Murray as he engages leading investigators in thoughtful discussions about the latest studies published in JVRD — highlighting practical insights, clinical pearls, and the real-world impact of emerging innovations in our field.

On this episode of the JVRD Author’s Forum podcast, retina specialist Akshay S. Thomas, MD, MS, FASRS, of Tennessee Retina, discusses his study, “A Time-Driven Activity-Based Costing Analysis of New Uveitis Patient Visits,” published in JVRD.

Host Timothy G. Murray, MD, MBA, speaks with Dr. Thomas about his team’s analysis of the true costs associated with caring for new uveitis patients. Using time-driven activity-based costing, the study captures the full scope of work surrounding these visits, including pre-visit coordination, in-clinic care, and post-visit management, and compares those costs to current reimbursement models.

Dr. Thomas explains that uveitis care is highly time-intensive and often financially unsustainable under existing reimbursement structures, contributing to ongoing workforce shortages and challenges in recruiting specialists. As access to uveitis care becomes increasingly limited, the conversation underscores that addressing these challenges will require a coordinated effort across the retina and ophthalmology communities.

For more information, visit www.ASRS.org/JVRDForum.

Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. As the official peer-reviewed scientific journal of the American Society of Retina Specialists (ASRS), JVRD delivers rigorous, clinically meaningful research that informs and advances retina care worldwide. Join Editor-in-Chief Dr. Timothy Murray as he engages leading investigators in thoughtful discussions about the latest studies published in JVRD — highlighting practical insights, clinical pearls, and the real-world impact of emerging innovations in our field.

On this episode of the JVRD Author’s Forum podcast, retina specialist Lisa J. Faia, MD, of Associated Retinal Consultants, discusses her case report, “Bilateral Peripheral Neovascularization in Hemoglobin C Trait Retinopathy,” published in JVRD.

Host Timothy G. Murray, MD, MBA, speaks with Dr. Faia about the evaluation of an asymptomatic 84-year-old patient referred for a suspected retinal tear, ultimately found to have bilateral peripheral neovascularization. The discussion highlights the diagnostic process, including a broad inflammatory and systemic workup, and the importance of considering hemoglobinopathies—even in older patients with atypical presentations.

Dr. Faia shares that in this case, careful observation was favored given the patient’s age, lack of symptoms, and stable findings. The conversation also explores how management decisions may differ in younger patients, the role of imaging in guiding care, and the importance of maintaining a broad differential diagnosis to identify unexpected but clinically meaningful findings in retina practice.

For more information, visit www.ASRS.org/JVRDForum.

Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. As the official peer-reviewed scientific journal of the American Society of Retina Specialists (ASRS), JVRD delivers rigorous, clinically meaningful research that informs and advances retina care worldwide. Join Editor-in-Chief Dr. Timothy Murray as he engages leading investigators in thoughtful discussions about the latest studies published in JVRD — highlighting practical insights, clinical pearls, and the real-world impact of emerging innovations in our field.

On this episode of the JVRD Author’s Forum podcast, retina specialist Sunir Garg, MD, FACS, FASRS, of Mid-Atlantic Retina and Wills Eye Hospital, discusses his study, “Short-Term Changes in Intraocular Pressure Following Intravitreal Injection of Pegcetacoplan,” published in JVRD.

Host Timothy G. Murray, MD, MBA, speaks with Dr. Garg about his team’s evaluation of short-term intraocular pressure (IOP) changes following higher-volume intravitreal injections and the implications for real-world clinical practice. The study examines the magnitude and duration of post-injection IOP elevations and whether routine monitoring is necessary in busy clinic settings.

Dr. Garg shares that while most patients experience transient IOP elevations that return to baseline relatively quickly, patients with preexisting glaucoma or ocular hypertension are more likely to experience higher and more prolonged pressure spikes. The discussion also highlights variability in injection techniques, considerations around post-injection monitoring and paracentesis, and the importance of identifying higher-risk patients to guide more tailored management strategies in retina care.

For more information, visit www.ASRS.org/JVRDForum.

Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. As the official peer-reviewed scientific journal of the American Society of Retina Specialists (ASRS), JVRD delivers rigorous, clinically meaningful research that informs and advances retina care worldwide. Join Editor-in-Chief Dr. Timothy Murray as he engages leading investigators in thoughtful discussions about the latest studies published in JVRD — highlighting practical insights, clinical pearls, and the real-world impact of emerging innovations in our field.

On this episode of the JVRD Author’s Forum podcast, retina specialist Dr. Sabin Dang of the Retina Institute in St. Louis discusses his study, “Economic Impact of Anti–Vascular Endothelial Growth Factor Prior Authorization Process From a Large Electronic Database,” published in JVRD.

Host Dr. Timothy Murray speaks with Dr. Dang about his team’s large database analysis examining the real-world burden of prior authorization for anti-VEGF injections. The study evaluated approval rates, treatment delays, and the broader economic consequences for patients, caregivers, practices, employers, and insurers.

Dr. Dang shares that although 97.7% of prior authorizations were ultimately approved, nearly all approved cases experienced delays — with a median delay of approximately five days — potentially affecting the timely delivery of vision-saving care. The discussion also highlights the growing prevalence of chronic retinal diseases requiring lifelong treatment, the compounding impact of repeated administrative hurdles over time, and the need for data-driven advocacy to support meaningful policy reform that prioritizes timely patient care.

For more information, visit www.ASRS.org/JVRDForum.

Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. As the official peer-reviewed scientific journal of the American Society of Retina Specialists (ASRS), JVRD delivers rigorous, clinically meaningful research that informs and advances retina care worldwide. Join Editor-in-Chief Dr. Timothy Murray as he engages leading investigators in thoughtful discussions about the latest studies published in JVRD — highlighting practical insights, clinical pearls, and the real-world impact of emerging innovations in our field.

On this episode of the JVRD Author’s Forum podcast, retina specialist Dr. Joseph Coney, Managing Partner of Retina Associates of Cleveland, discusses his study, “Real-World Clinical Outcomes After Sustained Delivery of the 0.19-mg Fluocinolone Acetonide Implant for the Treatment of Diabetic Macular Edema,” published in JVRD.

Host Dr. Timothy Murray speaks with Dr. Coney about his retrospective real-world analysis of patients with chronic, refractory diabetic macular edema treated with the fluocinolone acetonide implant. The study evaluated visual acuity, anatomic outcomes, treatment burden, and safety outside the clinical trial setting.

Dr. Coney shares that patients experienced durable visual stability and significant OCT improvement, along with a meaningful reduction in treatment burden — with some patients requiring no supplemental therapy for extended periods. The discussion also explores the importance of long-term disease stability over short-term visual gains, strategies to address injection fatigue, and the role of careful patient selection and steroid challenge testing in maintaining a predictable safety profile.

For more information, visit www.ASRS.org/JVRDForum.

Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. As the official peer-reviewed scientific journal of the American Society of Retina Specialists (ASRS), JVRD delivers rigorous, clinically meaningful research that informs and advances retina care worldwide. Join Editor-in-Chief Dr. Timothy Murray as he engages leading investigators in thoughtful discussions about the latest studies published in JVRD — highlighting practical insights, clinical pearls, and the real-world impact of emerging innovations in our field.